SE9902935D0 - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- SE9902935D0 SE9902935D0 SE9902935A SE9902935A SE9902935D0 SE 9902935 D0 SE9902935 D0 SE 9902935D0 SE 9902935 A SE9902935 A SE 9902935A SE 9902935 A SE9902935 A SE 9902935A SE 9902935 D0 SE9902935 D0 SE 9902935D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical compositions
- active ingredient
- propylsulphonyl
- phenylethoxy
- benzothiazol
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 125000005975 2-phenylethyloxy group Chemical group 0.000 abstract 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 1
- 208000027771 Obstructive airways disease Diseases 0.000 abstract 1
- 230000001078 anti-cholinergic effect Effects 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 abstract 1
- 239000003149 muscarinic antagonist Substances 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902935A SE9902935D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
| PCT/GB2000/003118 WO2001012167A2 (fr) | 1999-08-18 | 2000-08-14 | Compositions pharmaceutiques |
| AU64604/00A AU6460400A (en) | 1999-08-18 | 2000-08-14 | Pharmaceutical compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902935A SE9902935D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9902935D0 true SE9902935D0 (sv) | 1999-08-18 |
Family
ID=20416693
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9902935A SE9902935D0 (sv) | 1999-08-18 | 1999-08-18 | Pharmaceutical compositions |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU6460400A (fr) |
| SE (1) | SE9902935D0 (fr) |
| WO (1) | WO2001012167A2 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| DE10063957A1 (de) * | 2000-12-20 | 2002-06-27 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten |
| DE10111843A1 (de) * | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von inflammatorischen Erkrankungen |
| ES2329586T3 (es) | 2003-11-21 | 2009-11-27 | Theravance, Inc. | Compuestos que tienen actividad agonista del receptor beta2 adrenergico y antagonista del receptor muscarino. |
| TW200738658A (en) | 2005-08-09 | 2007-10-16 | Astrazeneca Ab | Novel compounds |
| TW200745067A (en) | 2006-03-14 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| TW200833670A (en) | 2006-12-20 | 2008-08-16 | Astrazeneca Ab | Novel compounds 569 |
| GB0702385D0 (en) * | 2007-02-07 | 2007-03-21 | Argenta Discovery Ltd | New combination |
| GB0702458D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | Salts 668 |
| EP2100599A1 (fr) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques |
| EP2100598A1 (fr) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques |
| CN102124003A (zh) | 2008-06-18 | 2011-07-13 | 阿斯利康(瑞典)有限公司 | 作为治疗呼吸系统疾病的β2肾上腺素受体拮抗剂的苯并噁嗪酮衍生物 |
| EP2510928A1 (fr) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9211172D0 (en) * | 1992-05-27 | 1992-07-08 | Fisons Plc | Compounds |
-
1999
- 1999-08-18 SE SE9902935A patent/SE9902935D0/xx unknown
-
2000
- 2000-08-14 AU AU64604/00A patent/AU6460400A/en not_active Abandoned
- 2000-08-14 WO PCT/GB2000/003118 patent/WO2001012167A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001012167A3 (fr) | 2001-09-20 |
| AU6460400A (en) | 2001-03-13 |
| WO2001012167A2 (fr) | 2001-02-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60228857D1 (de) | Amino-phtalazinon derivate, anwendung als kinase inhibitoren, herstellung und pharmazeutische zusammensetzung | |
| FR2808685B1 (fr) | Compositions pharmaceutiques pour administration transdermique d'agents anti-inflammatoires | |
| FR2673538B1 (fr) | Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale. | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| EA200301165A1 (ru) | Лекарственное средство на основе оксикодона | |
| MXPA04000920A (es) | Derivados de aminoisoxazol activos como inhibidores de la cinasa. | |
| WO2002085909A8 (fr) | Derives de 9-deazaguanine utilises comme inhibiteurs de la gsk-3 | |
| GEP20053600B (en) | 3-(4-Amidopyrrol-2-Ylmethlidene)-2- Indolinone Derivatives as Protein Kinase Inhibitors | |
| BR0108435A (pt) | Formulação e uso de entecavir de baixa dose | |
| CA2229597A1 (fr) | Compositions a dissolution rapide et administrees par voie orale, pour agonistes de la dopamine | |
| PT1240165E (pt) | Inibidores n-[5-[[[5-alquil-2-oxazolil]metil]tio]-2-tiazolil]carboxamida de quinases dependentes da ciclina | |
| CA2381097A1 (fr) | Derives d'arylmethyl-carbonylamino-thiazole utilisation de ceux-ci comme agents antitumoraux | |
| GEP20074208B (en) | Substituted amides active at the cannabinoid-1 receptor | |
| SE9902935D0 (sv) | Pharmaceutical compositions | |
| GEP20063890B (en) | Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis | |
| ITFI20030058A1 (it) | Formulazioni farmaceutiche contenenti tiazolidinedioni | |
| EE05127B1 (et) | Osadest koosnev komplekt ja ravimpreparaat, mis sisaldavad P2T-retseptori antagonisti v?i selle farmatseutiliselt vastuv?etavat derivaati ja tromboosivastast ainet, ning nende kasutamine meditsiinis | |
| EP1228758A4 (fr) | Agents de prevention ou de traitement de maladies inflammatoires de l'intestin | |
| WO2002011694A3 (fr) | Compositions et formes posologiques en vue d'une application dans la cavite orale dans le cadre du traitement de mycoses | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| SE9902937D0 (sv) | Pharmaceutical compositions | |
| SE9903995D0 (sv) | New combination | |
| HU9802897D0 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient | |
| CA2364178A1 (fr) | N-benzenesulfonyl-l-prolines utilisees comme antagonistes de la bradykinine | |
| SE9902938D0 (sv) | Pharmaceutical compositions |